검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | anti-CD19 CAR-NK cells |
Overview Company | Rui Therapeutics Co., Ltd |
Overview Modality | CGT |
Overview Target | CD19 |
Overview Indication | Refractory/Recurrent Central Nervous System Lymphoma |
Overview Phase | PHASE_1 |
Overview Status | ACTIVE |
MoA Mechanism | targets expressing the cognate antigen |
MoA Biomarker | CD19-Positive |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non-Hodgkin Lymphoma.. Resveratrol (RSV) is a dietary polyphenolic compound with anticancer property. However, its clinical translation as an anticancer chemotherapeutic agent is hindered by multiple challenges. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising immunotherapeutic strateg… |
Toxicology CRS | Reported |
Clinical ORR | 0% |
Clinical PFS | 0.95 |
Clinical OS | 8.9 |
Clinical Result source | ClinicalTrials.gov NCT05020015 |
Clinical Data Tier / Score | A · 34 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | anti-CD19 CAR-NK cells |
Overview Company | Rui Therapeutics Co., Ltd |
Overview Modality | CGT |
Overview Target | CD19 |
Overview Indication | Refractory/Recurrent Central Nervous System Lymphoma |
Overview Phase | PHASE_1 |
Overview Status | ACTIVE |
MoA Mechanism | targets expressing the cognate antigen |
MoA Biomarker | CD19-Positive |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non-Hodgkin Lymphoma.. Resveratrol (RSV) is a dietary polyphenolic compound with anticancer property. However, its clinical translation as an anticancer chemotherapeutic agent is hindered by multiple challenges. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising immunotherapeutic strateg… |
Toxicology CRS | Reported |
Clinical ORR | 0% |
Clinical PFS | 0.95 |
Clinical OS | 8.9 |
Clinical Result source | ClinicalTrials.gov NCT05020015 |
Clinical Data Tier / Score | A · 34 |
Clinical Program phase | PHASE_1 |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교